Unknown

Dataset Information

0

HLA-DQ B1*0201 and A1*0102 Alleles Are Not Responsible for Antituberculosis Drug-Induced Hepatotoxicity Risk in Spanish Population.


ABSTRACT:

Aims

To evaluate the role of human leukocyte antigen (HLA) class II DQB1*0201 and DQA1*0102 in the risk of antituberculosis drug (ATD)-induced hepatotoxicity (ATDH) in a cohort of tuberculosis patients of Caucasian origin from Spain.

Methods

Matched case-control study including active tuberculosis (TB) patients from Spain (Caucasian) treated with first-line ATD (Isoniazid, Rifampin, and Pyrazinamide). Presence or absence of HLA class II DQB1*0201 and DQA1*0102 alleles were compared between cases and controls.

Results

We included 110 TB patients, 55 ATDH cases, and 55 sex-matched controls. The analysis of the presence of HLA-DQB1*0201 and HLA-DQA*0102 did not show significative differences between both groups [presence of HLA-DQB1*0201 53.6% of the cases vs. 45.4% of the controls, OR: 1.63 95% CI (0.62-4.52) p = 0.38; presence of HLA-DQA*0102 7.5% of cases vs. 20% of controls, OR: 0.36 95% CI (0.08-1.23) p = 0.12]. After multivariate logistic regression analysis including in the model, other potential risk factors of hepatotoxicity HLA class II DQB1*0201 and DQA1*0102 alleles were not found significantly associated with the risk of development ATDH. We could not demonstrate an association between HLA-DQA1*0102 and HLA-DQB1*0201 with the risk of ATDH in this Caucasian population of Spanish origin.

SUBMITTER: Leiro-Fernandez V 

PROVIDER: S-EPMC4992991 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6105810 | biostudies-literature
| S-EPMC6379441 | biostudies-literature
| PRJNA1106236 | ENA
| S-EPMC2504520 | biostudies-literature
| S-EPMC9356556 | biostudies-literature
| S-EPMC4915850 | biostudies-other
| S-EPMC4616541 | biostudies-literature
| S-EPMC6491662 | biostudies-literature
| S-EPMC8238576 | biostudies-literature
| S-EPMC3706603 | biostudies-literature